Feature | February 28, 2014

First Pediatric Patient Treated on Mevion S250 Proton Therapy System

First Pediatric Patient Treated on Mevion S250 Proton Therapy System

February 28, 2014 — A 6-year-old with a highly malignant medulloblastoma brain tumor is the first pediatric patient treated using the Mevion S250 proton therapy system at Washington University Medical Center in St. Louis. This milestone event marks the first pediatric case ever treated on the world’s only single-room proton therapy system.

The Mevion S250 proton therapy system is a wholly unique proton therapy platform — a single-room, gantry-mounted proton accelerator that frees hospitals and private treatment facilities from the astronomical costs, prohibitive space requirements and technologically cumbersome systems that to date have defined this effective treatment modality.

The clinical team at S. Lee Kling Proton Therapy Center at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, along with doctors at St. Louis Children’s Hospital, is using the Mevion S250 for the treatment of brain, head and neck, and pediatric tumors, as well as other proton therapy indications.

Proton therapy delivers precise doses of radiation while limiting unnecessary radiation to healthy tissues, potentially reducing side effects and improving patient outcomes. “We selected proton therapy to be a part of this patient’s treatment plan due to the child’s age and the location of the tumor,” said Stephanie Perkins, M.D., a Washington University radiation oncologist at St. Louis Children’s Hospital. “Today's treatment lasted less than 45 minutes with the radiation beam hitting the tumor from three directions."

Mevion’s ability to provide this advanced treatment in a compact and integrated form is an industry first, leading the way in providing patients and clinicians’ access to the advanced treatment techniques proton therapy delivers in a far more cost-effective manner.

Five additional Mevion S250 proton therapy systems are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City; First Coast Oncology in Jacksonville, Fla.; University of Florida Health Cancer Center at Orlando Health; and University Hospitals Seidman Cancer Center in Cleveland.

For more information: www.mevion.com

Related Content

Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...